Question 1

What is ALG11-congenital disorder of glycosylation?

Accepted Answer

ALG11-congenital disorder of glycosylation is a rare genetic condition that affects the body’s ability to properly add sugars to proteins, a process known as glycosylation. This disorder is part of a group of conditions called congenital disorders of N-linked glycosylation, which can affect various systems in the body.

People with this condition may have facial differences such as a high forehead, low posterior hairline, small head size (microcephaly), and eye alignment issues (strabismus). Other problems that can occur include low muscle tone (hypotonia), challenges with growth and development, persistent vomiting, and gastrointestinal issues like gastric bleeding. In some cases, additional features such as unusual fat pad distribution, inverted nipples, and fluctuations in body temperature are observed.

Question 2

What are the symptoms of ALG11-congenital disorder of glycosylation?

Accepted Answer

Common symptoms include facial features such as microcephaly, a high forehead, a low posterior hairline, and strabismus. Other signs can include low muscle tone (hypotonia), failure to thrive, persistent vomiting, gastric bleeding, intractable seizures, and developmental delays. Additional features that may be seen in some people include anomalies in fat pads, inverted nipples, and body temperature changes.

Question 3

What causes ALG11-congenital disorder of glycosylation?

Accepted Answer

This condition is caused by mutations in the ALG11 gene, which is located on chromosome 13q14.3. Changes in this gene disrupt the normal process of glycosylation, leading to a range of symptoms observed in people with the disorder. Associated genes include ALG11.

Question 4

How is ALG11-congenital disorder of glycosylation inherited?

Accepted Answer

ALG11-congenital disorder of glycosylation follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is ALG11-congenital disorder of glycosylation?

Accepted Answer

ALG11-congenital disorder of glycosylation is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is ALG11-congenital disorder of glycosylation diagnosed?

Accepted Answer

Information about how the condition is diagnosed is currently limited for this condition.

Question 7

Are there treatments for ALG11-congenital disorder of glycosylation?

Accepted Answer

Information about treatment options and management approaches is currently limited for this condition.

Question 8

What complications can arise from ALG11-congenital disorder of glycosylation?

Accepted Answer

People with ALG11-congenital disorder of glycosylation can face various complications. These may include persistent vomiting, gastrointestinal issues like gastric bleeding, and developmental delays. Additionally, some individuals may experience intractable seizures and low muscle tone, which can impact their daily activities and overall well-being.

Question 9

How does ALG11-congenital disorder of glycosylation affect daily life?

Accepted Answer

Living with ALG11-congenital disorder of glycosylation can be challenging. Individuals may need extra support for growth and development, and they might face difficulties with muscle tone and coordination. Families often need to manage symptoms like vomiting and gastrointestinal issues, which can affect daily routines and activities.

Question 10

What is the prognosis for someone with ALG11-congenital disorder of glycosylation?

Accepted Answer

The prognosis for individuals with ALG11-congenital disorder of glycosylation is currently not well defined. Information about life expectancy and quality of life is limited, and it can vary widely among individuals. Ongoing research may provide more insights into the long-term outlook for those affected by this condition.

Question 11

What specific symptoms should families look for in ALG11-congenital disorder of glycosylation?

Accepted Answer

Families should be aware of several specific symptoms associated with ALG11-congenital disorder of glycosylation. These include facial features like a high forehead, low posterior hairline, and microcephaly. Other symptoms to watch for are low muscle tone, persistent vomiting, and developmental delays, which can help in managing the condition effectively.

Kisho

ALG11-congenital disorder of glycosylation

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Latest News & Developments

FDA Expands CRISPR Gene Therapy Casgevy to Children as Young as 2 with Sickle Cell Disease

ALG11-congenital disorder of glycosylation

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is ALG11-congenital disorder of glycosylation?

What are the symptoms of ALG11-congenital disorder of glycosylation?

What causes ALG11-congenital disorder of glycosylation?

How is ALG11-congenital disorder of glycosylation inherited?

How rare is ALG11-congenital disorder of glycosylation?

How is ALG11-congenital disorder of glycosylation diagnosed?

Are there treatments for ALG11-congenital disorder of glycosylation?

What complications can arise from ALG11-congenital disorder of glycosylation?

How does ALG11-congenital disorder of glycosylation affect daily life?

What is the prognosis for someone with ALG11-congenital disorder of glycosylation?

What specific symptoms should families look for in ALG11-congenital disorder of glycosylation?

Explore clinical features

Latest News & Developments

FDA Expands CRISPR Gene Therapy Casgevy to Children as Young as 2 with Sickle Cell Disease